Synthetic Biology – News and Features

A new study reports an AI-driven advance in biotechnology with implications for drug development, disease detection, and environmental monitoring.

Researchers have shown that RNA polymerase recognizes and transcribes artificial DNA base pairs in the same manner as it does natural base pairs.

Researchers have cracked the second "code of life". In an exclusive interview with Technology Networks they explain how.

This article explores how biopharmaceutical organizations seeking to remain competitive must adopt innovations, like cell-free long DNA synthesis, to unleash the potential of synthetic biology and accelerate therapeutic development across all facets of genetic medicine.

In 2021, a University-led research team received a contract worth up to $33 million to develop an implantable “living pharmacy” to control the human body’s sleep/wake cycles. Now, the researchers have completed a major step toward achieving this.

The Synthetic Yeast Genome Project 2.0 declares a major milestone: it has created a yeast strain comprising over 50% synthetic DNA.

Technology Networks spoke to Dr. Markus Gershater to learn more about Synthace's Lab automation & experimentation in life science R&D 2023-2024 report, its findings and their significance.

Researchers have engineered a strain of E. coli that can digest polyethylene terephthalate (PET) plastics and transform them into adipic acid – a useful feedstock for nylon materials, drugs and fragrances.

A recent discovery, published in PLoS Genetics, challenges the “rulebook” of DNA. We speak with the first author, Dr. Jamie McGowan, to learn about the accidental finding and what it means for synthetic biology.

The DNA double helix is composed of two DNA molecules whose sequences are complementary to each other. Researchers succeeded in creating fluorescent duplexes that can generate any of 16 million colors.